Redsense Medical AB (publ) (NGM:REDS)
7.12
+0.02 (0.28%)
At close: Feb 27, 2025
Redsense Medical AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Cash & Equivalents | 15.36 | 6.97 | 3.67 | 4.98 | 29.01 | Upgrade
|
Short-Term Investments | - | - | 6.91 | 21.97 | 36.02 | Upgrade
|
Cash & Short-Term Investments | 15.36 | 6.97 | 10.58 | 26.95 | 65.02 | Upgrade
|
Cash Growth | 120.44% | -34.17% | -60.74% | -58.55% | 647.81% | Upgrade
|
Accounts Receivable | 6.1 | 2.97 | 4.93 | 3.53 | 2.09 | Upgrade
|
Other Receivables | 0.2 | 1.2 | 0.33 | 0.67 | 0.89 | Upgrade
|
Receivables | 6.3 | 4.16 | 5.26 | 4.2 | 2.98 | Upgrade
|
Inventory | 5.99 | 1.36 | 1.53 | 1.38 | 2.34 | Upgrade
|
Prepaid Expenses | 0.35 | 0.76 | 0.64 | 0.41 | 0.4 | Upgrade
|
Other Current Assets | -0 | - | - | - | - | Upgrade
|
Total Current Assets | 27.99 | 13.24 | 18.01 | 32.94 | 70.73 | Upgrade
|
Property, Plant & Equipment | 0.31 | 0.36 | 0.37 | 0.37 | 2 | Upgrade
|
Long-Term Investments | - | - | - | - | 0.2 | Upgrade
|
Long-Term Deferred Charges | 13.5 | 12.91 | 12.35 | 9.94 | 5.77 | Upgrade
|
Other Long-Term Assets | - | 0 | -0 | - | - | Upgrade
|
Total Assets | 41.8 | 26.51 | 30.73 | 43.25 | 78.7 | Upgrade
|
Accounts Payable | 0.52 | 1.75 | 0.98 | 1.33 | 3.72 | Upgrade
|
Accrued Expenses | 1.45 | 1.46 | 2.14 | 0.84 | 1.26 | Upgrade
|
Other Current Liabilities | 0.25 | 0.2 | 0.47 | 1.02 | 0.53 | Upgrade
|
Total Current Liabilities | 2.21 | 3.41 | 3.58 | 3.19 | 5.51 | Upgrade
|
Long-Term Debt | - | - | - | 2.57 | - | Upgrade
|
Total Liabilities | 2.21 | 3.41 | 3.58 | 5.76 | 5.51 | Upgrade
|
Common Stock | 1.64 | 1.4 | 1.4 | 1.4 | 1.4 | Upgrade
|
Additional Paid-In Capital | - | - | - | 123.63 | 123.14 | Upgrade
|
Retained Earnings | 37.94 | 21.69 | 25.75 | -87.54 | -51.35 | Upgrade
|
Comprehensive Income & Other | 0 | - | - | 0 | - | Upgrade
|
Shareholders' Equity | 39.59 | 23.1 | 27.15 | 37.49 | 73.2 | Upgrade
|
Total Liabilities & Equity | 41.8 | 26.51 | 30.73 | 43.25 | 78.7 | Upgrade
|
Total Debt | - | - | - | 2.57 | - | Upgrade
|
Net Cash (Debt) | 15.36 | 6.97 | 10.58 | 24.38 | 65.02 | Upgrade
|
Net Cash Growth | 120.44% | -34.17% | -56.60% | -62.51% | 777.77% | Upgrade
|
Net Cash Per Share | 0.93 | 0.49 | 0.75 | 1.74 | 4.63 | Upgrade
|
Filing Date Shares Outstanding | 16.44 | 14.04 | 14.04 | 14.04 | 14.04 | Upgrade
|
Total Common Shares Outstanding | 16.44 | 14.04 | 14.04 | 14.04 | 14.04 | Upgrade
|
Working Capital | 25.78 | 9.83 | 14.43 | 29.75 | 65.23 | Upgrade
|
Book Value Per Share | 2.41 | 1.64 | 1.93 | 2.67 | 5.21 | Upgrade
|
Tangible Book Value | 39.59 | 23.1 | 27.15 | 37.49 | 73.2 | Upgrade
|
Tangible Book Value Per Share | 2.41 | 1.64 | 1.93 | 2.67 | 5.21 | Upgrade
|
Machinery | - | 0.53 | 0.48 | 0.43 | 2.05 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.